12 Stocks that Will Bounce Back According to Wall Street Analysts
On January 5, Reuters reported that many analysts believe global investors will actively look for opportunities in undervalued areas of the financial markets in 2026.
Alvotech (ALVO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bracebridge Capital Nancy Zimmerman And Gabriel Sunshine | 2,705,304 | $22,156,440 | 1.16% | |
| 2. | Oaktree Capital Management Howard Marks | 1,563,676 | $12,806,506 | 0.2% | |
| 3. | Point State Capital Zach Schreiber | 1,049,039 | $8,591,629 | 0.13% | |
| 4. | 4,666,667 | $7,087,733 | 0.11% | ||
| 5. | Farallon Capital Thomas Steyer | 199,675 | $1,635,338 | 0.01% |
Institutional Investors' Holdings
News See All
Alvotech (ALVO): Firm Reaffirms 2025 Growth Outlook
The firm recently launched a $100 million offering of senior unsecured convertible notes due 2030 and reaffirmed its 2025 outlook while providing initial guidance for 2026.
15 Stocks That Could Mint Millionaires in 2026
For more than a century, investing in the stock market in the United States has represented one of the most accessible paths to generating substantial wealth for the amateur investor, with a long and ...
Alvotech (ALVO): A Bull Case Theory
We came across a bullish thesis on Alvotech on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on ALVO.
Alvotech (NASDAQ:ALVO) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Alvotech Q3 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma
Alvotech (NASDAQ:ALVO) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.
13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Alvotech (ALVO): A Bull Case Theory
We came across a bullish thesis on Alvotech (ALVO) on M.V Cunha’s Substack. In this article, we will summarize the bulls’ thesis on ALVO.
11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.